Tuesday, November 11, 2014

Neuropsychopharmacology - Table of Contents alert Volume 39 Issue 13

If you are unable to see the message below, click here to view.
Neuropsychopharmacology

TABLE OF CONTENTS

Volume 39, Issue 13 (December 2014)

In this issue
Original Articles
In Memoriam

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Original Articles

Top

Exaggerated Waiting Impulsivity Associated with Human Binge Drinking, and High Alcohol Consumption in Mice

Sandra Sanchez-Roige, Victor Baro, Leanne Trick, Yolanda Peña-Oliver, David N Stephens and Theodora Duka

Neuropsychopharmacology 2014 39: 2919-2927; advance online publication, June 11, 2014; 10.1038/npp.2014.151

Abstract | Full Text

Facilitation of Serotonin Signaling by SSRIs is Attenuated by Social Isolation

Elyse C Dankoski, Kara L Agster, Megan E Fox, Sheryl S Moy and R Mark Wightman

Neuropsychopharmacology 2014 39: 2928-2937; advance online publication, July 1, 2014; 10.1038/npp.2014.162

Abstract | Full Text

The PDE4 Inhibitor HT-0712 Improves Hippocampus-Dependent Memory in Aged Mice

Marco Peters, Matthew Bletsch, Jennifer Stanley, Damian Wheeler, Roderick Scott and Tim Tully

Neuropsychopharmacology 2014 39: 2938-2948; advance online publication, June 26, 2014; 10.1038/npp.2014.154

Abstract | Full Text

Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease

Teng Jiang, Lan Tan, Xi-Chen Zhu, Qiao-Quan Zhang, Lei Cao, Meng-Shan Tan, Li-Ze Gu, Hui-Fu Wang, Zheng-Zheng Ding, Ying-Dong Zhang and Jin-Tai Yu

Neuropsychopharmacology 2014 39: 2949-2962; advance online publication, July 3, 2014; 10.1038/npp.2014.164

Abstract | Full Text

Impaired Adrenergic-Mediated Plasticity of Prefrontal Cortical Glutamate Synapses in Rats with Developmental Disruption of the Ventral Hippocampus

Sanjeev K Bhardwaj, Yiu Chung Tse, Richard Ryan, Tak Pan Wong and Lalit K Srivastava

Neuropsychopharmacology 2014 39: 2963-2973; advance online publication, June 11, 2014; 10.1038/npp.2014.142

Abstract | Full Text

Effects of Genetic Deletion of Endogenous Opioid System Components on the Reinstatement of Cocaine-Seeking Behavior in Mice

Javier Gutiérrez-Cuesta, Aurelijus Burokas, Samantha Mancino, Sami Kummer, Elena Martín-García and Rafael Maldonado

Neuropsychopharmacology 2014 39: 2974-2988; advance online publication, June 19, 2014; 10.1038/npp.2014.149

Abstract | Full Text

Association of Adenosine Receptor Gene Polymorphisms and In Vivo Adenosine A1 Receptor Binding in The Human Brain

Christa Hohoff, Valentina Garibotto, David Elmenhorst, Anna Baffa, Tina Kroll, Alana Hoffmann, Kathrin Schwarte, Weiqi Zhang, Volker Arolt, Jürgen Deckert and Andreas Bauer

Neuropsychopharmacology 2014 39: 2989-2999; advance online publication, June 19, 2014; 10.1038/npp.2014.150

Abstract | Full Text

Effects of Dopamine D2/D3 Blockade on Human Sensory and Sensorimotor Gating in Initially Antipsychotic-Naive, First-Episode Schizophrenia Patients

Signe Düring, Birte Y Glenthøj, Gitte Saltoft Andersen and Bob Oranje

Neuropsychopharmacology 2014 39: 3000-3008; advance online publication, July 23, 2014; 10.1038/npp.2014.152

Abstract | Full Text

Amylin Receptor Signaling in the Nucleus Accumbens Negatively Modulates μ-opioid-Driven Feeding

Sarah K Baisley and Brian A Baldo

Neuropsychopharmacology 2014 39: 3009-3017; advance online publication, July 24, 2014; 10.1038/npp.2014.153

Abstract | Full Text

Modafinil Effects on Middle-Frequency Oscillatory Power During Rule Selection in Schizophrenia

Michael J Minzenberg, Jong H Yoon, Yaoan Cheng and Cameron S Carter

Neuropsychopharmacology 2014 39: 3018-3026; advance online publication, July 23, 2014; 10.1038/npp.2014.155

Abstract | Full Text

Brain Oxytocin in Social Fear Conditioning and Its Extinction: Involvement of the Lateral Septum

Iulia Zoicas, David A Slattery and Inga D Neumann

Neuropsychopharmacology 2014 39: 3027-3035; advance online publication, June 26, 2014; 10.1038/npp.2014.156

Abstract | Full Text

Kappa Opioid Receptor Activation Potentiates the Cocaine-Induced Increase in Evoked Dopamine Release Recorded In Vivo in the Mouse Nucleus Accumbens

Jonathan M Ehrich, Paul E M Phillips and Charles Chavkin

Neuropsychopharmacology 2014 39: 3036-3048; advance online publication, June 27, 2014; 10.1038/npp.2014.157

Abstract | Full Text

Dopamine D3 Receptors in the Basolateral Amygdala and the Lateral Habenula Modulate Cue-Induced Reinstatement of Nicotine Seeking

Maram ATM Khaled, Abhiram Pushparaj, Patricia Di Ciano, Jorge Diaz and Bernard Le Foll

Neuropsychopharmacology 2014 39: 3049-3058; advance online publication, July 7, 2014; 10.1038/npp.2014.158

Abstract | Full Text

‘Can you look me in the face?’ Short-term SSRI Administration Reverts Avoidant Ocular Face Exploration in Subjects at Risk for Psychopathology OPEN

Martina Di Simplicio, Sonia Doallo, Giulia Costoloni, Gustavo Rohenkohl, Anna C Nobre and Catherine J Harmer

Neuropsychopharmacology 2014 39: 3059-3066; advance online publication, July 18, 2014; 10.1038/npp.2014.159

Abstract | Full Text

Dopamine Modulation of GABAergic Function Enables Network Stability and Input Selectivity for Sustaining Working Memory in a Computational Model of the Prefrontal Cortex

Sergio E Lew and Kuei Y Tseng

Neuropsychopharmacology 2014 39: 3067-3076; advance online publication, June 30, 2014; 10.1038/npp.2014.160

Abstract | Full Text

Effect of GABRA2 Genotype on Development of Incentive-Motivation Circuitry in a Sample Enriched for Alcoholism Risk

Mary M Heitzeg, Sandra Villafuerte, Barbara J Weiland, Mary-Anne Enoch, Margit Burmeister, Jon-Kar Zubieta and Robert A Zucker

Neuropsychopharmacology 2014 39: 3077-3086; advance online publication, June 30, 2014; 10.1038/npp.2014.161

Abstract | Full Text

Disrupted Gamma-Band Neural Oscillations During Coherent Motion Perception in Heavy Cannabis Users

Patrick D Skosnik, Giri P Krishnan, Deepak C D'Souza, William P Hetrick and Brian F O'Donnell

Neuropsychopharmacology 2014 39: 3087-3099; advance online publication, July 3, 2014; 10.1038/npp.2014.166

Abstract | Full Text

Reduced Phenotypic Severity Following Adeno-Associated Virus-Mediated Fmr1 Gene Delivery in Fragile X Mice

Shervin Gholizadeh, Jason Arsenault, Ingrid Cong Yang Xuan, Laura K Pacey and David R Hampson

Neuropsychopharmacology 2014 39: 3100-3111; advance online publication, July 7, 2014; 10.1038/npp.2014.167

Abstract | Full Text

Reduced Dopamine Transporter Functioning Induces High-Reward Risk-Preference Consistent with Bipolar Disorder

Jordy van Enkhuizen, Brook L Henry, Arpi Minassian, William Perry, Morgane Milienne-Petiot, Kerin K Higa, Mark A Geyer and Jared W Young

Neuropsychopharmacology 2014 39: 3112-3122; advance online publication, July 9, 2014; 10.1038/npp.2014.170

Abstract | Full Text

In Memoriam

Top

George Bartzokis

Mark Wheeler

Neuropsychopharmacology 2014 39: 3123-3124; 10.1038/npp.2014.246

Full Text

Enoch Callaway

David Braff

Neuropsychopharmacology 2014 39: 3125; 10.1038/npp.2014.247

Full Text

Merton Sandler

Gregory Oxenkrug and David Healy

Neuropsychopharmacology 2014 39: 3126-3127; 10.1038/npp.2014.248

Full Text

Daniel W. Hommer

Markus A Heilig

Neuropsychopharmacology 2014 39: 3128; 10.1038/npp.2014.249

Full Text

Nancy Kishlar Mello

Marc A Schuckit

Neuropsychopharmacology 2014 39: 3129-3130; 10.1038/npp.2014.250

Full Text

Joseph Clayton Schoolar

Kanellos Charalampous

Neuropsychopharmacology 2014 39: 3131; 10.1038/npp.2014.251

Full Text

Ellen Stover

Charles B Nemeroff, Stephen R Marder and Jeffrey Lieberman

Neuropsychopharmacology 2014 39: 3132; 10.1038/npp.2014.252

Full Text

Turan M Itil

Max Fink

Neuropsychopharmacology 2014 39: 3133-3134; 10.1038/npp.2014.253

Full Text

Harry L June

Phil Skolnick

Neuropsychopharmacology 2014 39: 3135; 10.1038/npp.2014.254

Full Text

William L Woolverton

Robert L Balster

Neuropsychopharmacology 2014 39: 3136; 10.1038/npp.2014.255

Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: